1011 related articles for article (PubMed ID: 33793673)
21. High SARS-CoV-2 Prevalence among Healthcare Workers in Cochabamba, Bolivia.
Saba Villarroel PM; Castro Soto MDR; Undurraga V; Sanz H; Jaldín AM; Ninove L; Nurtop E; Pezzi L; Mohamed Ali S; Amroun A; Seston M; de Lamballerie X
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215826
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
24. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
[TBL] [Abstract][Full Text] [Related]
26. High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali.
Somboro AM; Cissoko Y; Camara I; Kodio O; Tolofoudie M; Dembele E; Togo ACG; Ba DM; Sarro YDS; Baya B; Samake S; Diallo IB; Kumar A; Traore M; Kone B; Kone A; Diarra B; Dabitao DK; Wague M; Dabo G; Doumbia S; Holl JL; Murphy RL; Diallo S; Maiga AI; Maiga M; Dao S
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062306
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
[TBL] [Abstract][Full Text] [Related]
29. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
[TBL] [Abstract][Full Text] [Related]
34. Sero-prevalence of anti-SARS-CoV-2 antibodies among healthcare workers: A multicenter study from Egypt.
El-Sokkary RH; Daef E; El-Korashi LA; Khedr EM; Gad D; Mohamed-Hussein A; Zayed NE; Mostafa EF; Bahgat SM; Hassany SM; Amer MG; El-Mokhtar MA; Elantouny NG; Hassan SA; Zarzour AA; Hashem MK; Amin MT; Hassan HM
J Infect Public Health; 2021 Oct; 14(10):1474-1480. PubMed ID: 34556461
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves.
de Visscher N; Holemans X; Gillain A; Kornreich A; Lagasse R; Piette P; Ventura M; Thys F
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891515
[No Abstract] [Full Text] [Related]
36. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
[No Abstract] [Full Text] [Related]
37. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
[TBL] [Abstract][Full Text] [Related]
38. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study.
Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG
Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092
[TBL] [Abstract][Full Text] [Related]
39. Provider Antibody Serology Study of Virus in the Emergency Room (PASSOVER) Study: Special Population COVID-19 Seroprevalence.
Heyming TW; Sanger T; Tongol A; Schomberg J; Bacon K; Lara B
West J Emerg Med; 2021 Apr; 22(3):565-571. PubMed ID: 34125028
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
Marklund E; Leach S; Nyström K; Lundgren A; Liljeqvist JÅ; Nilsson S; Yilmaz A; Andersson LM; Bemark M; Gisslén M
Front Immunol; 2021; 12():750448. PubMed ID: 34795668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
